Alto Neuroscience, Inc. (ANRO) Total Return Calculator with Dividends Reinvested

Alto Neuroscience, Inc.

Popular:

The total return for Alto Neuroscience, Inc. (ANRO) stock is +776.33% over the past 12 months. So far it's up 29.42% this year. The 5-year total return is +3.72%, meaning $10,000 invested in ANRO stock 5 years ago would be worth $10,372 today. Total return includes price appreciation plus reinvesting any dividends paid out.

If you invested $10,000 in ANRO 1 year ago, it would be worth $89,087 today — you'd have gained $79,087.

With Dividends Reinvested$89,087+790.87%

Price Only (No DRIP)$89,087+790.87%

Period2025-06-13 → 2026-06-12

Price

Total Return (DRIP)

S&P 500

If You Invested $10,000 in ANRO

1Y$87,633+$77,633 (+776.3%)776.3% CAGR

3Y$10,372+$372 (+3.7%)1.2% CAGR

5Y$10,372+$372 (+3.7%)0.7% CAGR

10Y$10,372+$372 (+3.7%)0.4% CAGR

15Y$10,372+$372 (+3.7%)0.2% CAGR

20Y$10,372+$372 (+3.7%)0.2% CAGR

30Y$10,372+$372 (+3.7%)0.1% CAGR

Alto Neuroscience, Inc. did not pay dividends during this period. Total return = price return.

Loading ANRO total return...

As of 2026-06-13

Returns at a Glance

Period	Total Return	CAGR	Price Only	Div. Contrib.	$10K →
YTD	+29.42%	—	+29.42%	—	$12,942
1Y	+776.33%	776.33%	+776.33%	—	$87,633
3Y	+3.72%	1.22%	+3.72%	—	$10,372
5Y	+3.72%	0.73%	+3.72%	—	$10,372
10Y	+3.72%	0.37%	+3.72%	—	$10,372
15Y	+3.72%	0.24%	+3.72%	—	$10,372
20Y	+3.72%	0.18%	+3.72%	—	$10,372
30Y	+3.72%	0.12%	+3.72%	—	$10,372

Risk & Highlights

Best Year+306.39%2025

Worst Year-79.57%2024

Max Drawdown-34.20%2026-04-17 → 2026-06-08

Annual Returns

Year	Total Return	Price Return	Div.	S&P 500	vs S&P
2026YTD	+18.69%	+18.69%	—	+0.41%	+18.3pp
2025	+306.39%	+306.39%	—	+16.64%	+289.8pp
2024	-79.57%	-79.57%	—	+24.00%	-103.6pp

ANRO outperformed the S&P 500 by 753.47pp over the past year (+776.33% vs +22.86%).

Loading summary...

ANRO Peers' Total Return

Accurate peer set · 10 comparable names

Name	Mkt Cap	30D Rtn	YTD Total Rtn	1Y Total Rtn	Div Contrib	3Y Total Rtn	5Y Total Rtn	10Y Total Rtn
ANROAlto Neuroscience, Inc.	$753M	-12.8%	+29.4%	+776.3%	—	+3.7%	+3.7%	+3.7%
SAVACassava Sciences, Inc.	$64M	+0.0%	-36.8%	-37.7%	—	-62.5%	-87.8%	-38.0%
NRXPNRx Pharmaceuticals, Inc.	$66M	+33.8%	+46.6%	+11.6%	—	-28.2%	-97.9%	-96.0%
INVAInnoviva, Inc.	$1.7B	+0.0%	+14.4%	+6.3%	—	+69.7%	+77.9%	+108.1%
ACADACADIA Pharmaceuticals Inc.	$3.6B	-2.9%	-19.3%	-3.0%	—	-14.3%	-22.6%	-44.6%
AXSMAxsome Therapeutics, Inc.	$13.1B	+13.9%	+42.8%	+140.2%	—	+241.0%	+277.9%	+3550.5%
INTRInter & Co, Inc.	$2.5B	-9.8%	-30.4%	-17.4%	+1.6pp	+84.4%	+72.2%	+72.2%
PRAXPraxis Precision Medicines, Inc.	$7.7B	-22.3%	-6.9%	+491.9%	—	+1757.4%	-14.2%	-36.1%
ILMNIllumina, Inc.	$24.5B	+10.5%	+19.8%	+82.7%	—	-20.4%	-63.4%	+18.6%
TMOThermo Fisher Scientific Inc.	$174.4B	+2.2%	-20.7%	+13.4%	+0.4pp	-9.5%	+1.4%	+219.0%
CRLCharles River Laboratories International, Inc.	$9.0B	+11.2%	-7.4%	+23.5%	—	-8.7%	-47.2%	+122.4%

Compare:ANRO vs SAVA ANRO vs NRXP ANRO vs INVA ANRO vs SAVA vs NRXP

About ANRO Dividend Returns

Alto Neuroscience, Inc. (ANRO) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.

How We Calculate Total Return

Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.

Frequently Asked Questions

Q1What is the total return of ANRO over the past year?

Alto Neuroscience, Inc. (ANRO) delivered a return of 776.33% over the past year. Since ANRO does not currently pay dividends, the total return equals the price-only return.

Q2How much would $10,000 invested in ANRO be worth today?

A $10,000 investment in Alto Neuroscience, Inc. one year ago would be worth $87,633 today, representing a gain of $77,633.

Q3Does ANRO pay dividends?

Alto Neuroscience, Inc. (ANRO) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For ANRO, the total return equals the price-only return.

Q4Did ANRO beat the S&P 500?

Yes, Alto Neuroscience, Inc. (ANRO) outperformed the S&P 500 by 753.47 percentage points over the past year. ANRO delivered a total return of 776.33%, compared to the S&P 500's 22.86%. This 753.47pp alpha means investors in ANRO earned more than a passive S&P 500 index fund.

Q5What is ANRO's worst drawdown?

Alto Neuroscience, Inc. (ANRO) experienced a maximum drawdown of -34.20% over the past year, declining from its peak on 2026-04-17 to its trough on 2026-06-08. The stock has not yet fully recovered to its prior peak. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Q6What is ANRO's long-term total return over 10, 20, or 30 years?

Here are Alto Neuroscience, Inc. (ANRO)'s long-term returns with dividends reinvested. Over 10 years, the total return is 3.7% (0.4% CAGR) — $10,000 would have grown to $10,372. Over 20 years: 3.7% total return (0.2% CAGR) — $10,000 → $10,372. Over 30 years: 3.7% total return (0.1% CAGR) — $10,000 → $10,372. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Q7What was ANRO's best and worst year?

Alto Neuroscience, Inc.'s best calendar year was 2025 with a total return of 306.4%. Its worst year was 2024 with a total return of -79.6%. This range shows the volatility investors should expect — the difference between the best and worst year is 386.0 percentage points.

How much would $100/month in ANRO be worth today?

Dollar cost averaging calculator · DCA vs lump sum · see how regular investing compounds

Run the Numbers →